Patients with previous heparin-induced thrombocytopenia, or HIT, who were re-exposed to heparin demonstrated a low risk for recurrent HIT, yet the development of strong heparin-independent platelet-activating antibodies increased that risk, according to study results.
The analysis included 20 patients who had previous HIT. Of these patients, 17 received intraoperative heparin during cardiac/vascular surgery.
Full Story »
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.